Literature DB >> 21972082

Liver X receptors regulate cholesterol homeostasis in oligodendrocytes.

Katherine Nelissen1, Monique Mulder, Ilse Smets, Silke Timmermans, Karen Smeets, Marcel Ameloot, Jerome J A Hendriks.   

Abstract

Cholesterol synthesis and transport in oligodendrocytes are essential for optimal myelination and remyelination in pathological conditions such as multiple sclerosis. However, little is known about cholesterol homeostasis in the myelin-forming oligodendrocytes. Liver X receptors (LXRs) are nuclear oxysterol receptors that regulate genes involved in cholesterol homeostasis and may therefore play an important role in de- and remyelination. We investigated whether LXRs regulate cholesterol homeostasis in oligodendrocytes. mRNA expression of genes encoding LXR-α and LXR-β and their target genes (ABCA1, ABCG1, ABCG4, apoE, and LDLR) was detected in oligodendrocytes derived from both neonatal and adult rats using quantitative real-time PCR. The expression of LXR-β and several target genes was increased during oligodendrocyte differentiation. We further demonstrated that treatment of primary neonatal rat oligodendrocytes with the synthetic LXR agonist T0901317 induced the expression of several established LXR target genes, including ABCA1, ABCG1, apoE, and LDLR. Treatment of oligodendrocytes with T0901317 resulted in an enhanced cholesterol efflux in the presence of apolipoprotein A-I or high-density lipoprotein particles. These data show that LXRs are involved in regulating cholesterol homeostasis in oligodendrocytes.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21972082     DOI: 10.1002/jnr.22743

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  24 in total

Review 1.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 2.  LXR agonists: new potential therapeutic drug for neurodegenerative diseases.

Authors:  Pei Xu; Dabing Li; Xiaotong Tang; Xiaohang Bao; Jing Huang; Yongping Tang; Yang Yang; Haiwei Xu; Xiaotang Fan
Journal:  Mol Neurobiol       Date:  2013-04-27       Impact factor: 5.590

Review 3.  PET imaging in multiple sclerosis.

Authors:  Daniele de Paula Faria; Sjef Copray; Carlos Buchpiguel; Rudi Dierckx; Erik de Vries
Journal:  J Neuroimmune Pharmacol       Date:  2014-05-09       Impact factor: 4.147

Review 4.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

Review 5.  APOE in the normal brain.

Authors:  Sarah A Flowers; G William Rebeck
Journal:  Neurobiol Dis       Date:  2020-01-03       Impact factor: 5.996

Review 6.  Liver X receptors, nervous system, and lipid metabolism.

Authors:  G Cermenati; E Brioschi; F Abbiati; R C Melcangi; D Caruso; N Mitro
Journal:  J Endocrinol Invest       Date:  2013-04-18       Impact factor: 4.256

Review 7.  LXR Regulation of Brain Cholesterol: From Development to Disease.

Authors:  Rebecca Courtney; Gary E Landreth
Journal:  Trends Endocrinol Metab       Date:  2016-04-21       Impact factor: 12.015

Review 8.  Regenerating CNS myelin - from mechanisms to experimental medicines.

Authors:  Robin J M Franklin; Charles Ffrench-Constant
Journal:  Nat Rev Neurosci       Date:  2017-11-16       Impact factor: 34.870

9.  Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.

Authors:  Delphine Meffre; Ghjuvan'Ghjacumu Shackleford; Mehdi Hichor; Victor Gorgievski; Eleni T Tzavara; Amalia Trousson; Abdel M Ghoumari; Cyrille Deboux; Brahim Nait Oumesmar; Philippe Liere; Michael Schumacher; Etienne-Emile Baulieu; Frédéric Charbonnier; Julien Grenier; Charbel Massaad
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-28       Impact factor: 11.205

10.  Differential regulation of ABCA1 and ABCG1 gene expressions in the remodeling mouse hippocampus after entorhinal cortex lesion and liver-X receptor agonist treatment.

Authors:  Stéphanie Bélanger Jasmin; Vanessa Pearson; Daphnée Lalonde; Dorothée Domenger; Louise Théroux; Judes Poirier
Journal:  Brain Res       Date:  2014-03-21       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.